Decibel Bio, a Berkeley, CA-based epigenetic reprogramming platform supplier, raised $12M in funding.
Backers included Breakthrough Power Ventures, Future Ventures, Bayer and Syngenta.
The corporate intends to make use of the funds to increase partnerships throughout the platform and quick monitor product growth.
Led by CEO and Founder Travis Bayer, Decibel gives an epigenetic reprogramming platform that enables farmers to use a remedy that reinforces the genes that defend the plant’s photosynthetic equipment from excessive warmth, preserving it productive as an alternative of shutting down beneath stress. This identical method works for drought, extra rainfall, and even yield enhancement.
The corporate goals to advance its proprietary platform for each studying and writing the plant epigenome to create crop varieties with larger yield, effectivity, and resilience to a altering surroundings.
FinSMEs
05/03/2025
